InvestorsHub Logo
Followers 0
Posts 90
Boards Moderated 0
Alias Born 10/25/2014

Re: None

Saturday, 08/20/2016 11:52:52 PM

Saturday, August 20, 2016 11:52:52 PM

Post# of 16695
During the month of July 2016, the Company has been focusing on
advancing both the FAIMS and Na-Nose technology platforms. The
Company has been developing our clinical study protocol and IRB
submission for our Na-Nose clinical study being conducted in Vancouver
with a planned start of late Q3/early Q4 2016

LINK